An energy systems approach to Parkinson's disease

Wiley Interdisciplinary Reviews: Systems Biology and Medicine

Volumn 3, Issue 1, 2011, Pages 1-6

  Wellstead, Peter ^a   Cloutier, Mathieu ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE;

ARTICLE; BRAIN; ENERGY METABOLISM; HUMAN; METABOLISM; PARKINSON DISEASE; PHYSIOLOGY;

ADENOSINE TRIPHOSPHATE; BRAIN; ENERGY METABOLISM; HUMANS; PARKINSON DISEASE;

EID: 79953243143     PISSN: 19395094     EISSN: 1939005X     Source Type: Journal    
DOI: 10.1002/wsbm.107     Document Type: Article

References (24)

1. Dawson TM, Dawson VL. Molecular pathways of neurodegeneration in Parkinson's disease. Science 2002, 302:819-821.
2. von Bohlen und Halbach O, Schober A, Krieglstein K. Genes, proteins, and neurotoxins involved in Parkinson's disease. Prog Neurobiol 2004, 73: 151-177.
3. Lotharius J, Brundin P. Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein. Nat Rev Neurosci 2002, 3:932-942.
4. Roberts SB, Rosenberg I. Nutrition and aging: changes in the regulation of energy metabolism with aging. Physiol Rev 2006, 86:651-667.
5. de Rijk MC, Tzourio C, Breteler MM, Dartigues JK, Amaducci L, Lopez-Pousa S, Manuben-Bertran JM, Aplerovitch A, Rocca WA. Prevalence of parkinsonism and Parkinson's disease in Europe: the EUROPARKINSON collaborative study. European Community concerted action on the epidemiology of Parkinson's disease. J Neurol Neurosurg Psychiatr 1997, 62:10-15.
6. Willis MW, Ketterb TA, Kimbrell TA, George MS, Herscovitch P, Danielson AL, Benson BE, Post RM. Age, sex and laterality effects on cerebral glucose metabolism in healthy adults. PsychiatrResNeuroimaging 2002, 114:23-37.
7. Braak H, Del Tredici K. Poor and protracted myelination as a contributory factor in neurodegenerative disorders. Neurobiol Aging 2004, 25:19-23.
8. Litvan I, Halliday G, Hallett M, Goetz CG, Rocca W, Duyckaerts C, Ben-Shlomo Y, Dickson D, Lang AE, Chesselet M-F, et al. The etiopathogenesis of Parkinson's disease and suggestions for future research. Part J Neuropathol Exp Neurol 2007, 66:251-257.
9. Litvan I, Chesselet M-F, Gasser T, Di Monte DA, Parker D, Hagg T, Hardy J, Jenner P, Myers RH, Price DL, et al. The etiopathogenesis of Parkinson's disease and suggestions for future research. Part 2. J Neuropathol Exp Neurol 2007, 66:329-336.
10. Bower JH, Maraganore DM, Peterson BJ, Mc-Donnell SK, Ahlskog JE, Rocca WA. Head trauma preceding PD: a case-control study. Neurology 2003, 60:1610-1615.
11. Malkus KAE, Tsika E, Ischiropoulos H. Oxidative modifications, mitochondrial dysfunction, and impaired protein degradation in Parkinson's disease: how neurons are lost in the Bermuda triangle. Mol Neurodegeneration 2009, 4:(on-line first).
12. Cookson MR. Alpha-Synuclein and neuronal cell death. Mol Neurodegeneration 2009, 4:(on-line first).
13. Chan CS, Gertler TS, Surmeier DJ. Calcium homeostasis, selective vulnerability and Parkinson's disease. Trends Neurosci 2009, 32:249-256.
14. Pellerin L, Magistretti PJ. Glutamate uptake into astrocytes stimulates aerobic glycolysis. PNAS 1994, 91: 10625-10629.
15. Attwell D, Laughlin SB. An energy budget for signalling in the grey matter of the brain. J Cereb Blood Flow Metab 2001, 21:1133-1145.
16. Matsuda W, Furuta T, Nakamura KC, Hioki H, Fujiyama F, Arai R, Kaneko T. Single nigrostratal dopaminergic neurons form widely spread and high dense axonal arborisations in the neostriatum. J Neurosci 2009, 29:444-445.
17. Moss J, Bolam JP. The relationship between dopaminergic axons and glutamatergic synapses in the striatum: structural considerations. In: Dunnett S, Iversen S, Iversen L, eds. Dopamine 50 Years. Oxford: OUP; 2010, 281-283.
18. Chergui K, Charléty PJ, Akaoka H, Saunier CF, Brunet J-L, Buda M, Svensson TH, Chouvet G. Tonic activation of NMDA receptors causes spontaneous burst discharge of rat midbrain dopamine neurons in vivo. Eur J Neurosci 2006, 5:137-144.
19. Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. Science 1983, 219: 979-980.
20. Dauer W, Przedborski S. Parkinson's disease: mechanisms and models. Neuron 2003, 39:889-909.
21. Henchcliffe C, Flint Beal M. Pathogenesis: oxidative stress, mitochondrial dysfunction and excitotoxicity. In: Factor SA, Weiner WJ, eds. Parkinson's Disease: Diagnosis and Clinical Management. New York: Demos Medical Publishing; 2008, 341-356.
22. Aubert J, Costalat R. Interactions between astrocytes and neurons studied using a mathematical model of compartmentalised energy metabolism. J Cereb Blood Flow Metab 2005, 3:1476-1490.
23. Cloutier M, Wellstead P. The control systems structures of energy metabolism. J R Soc Interface 2009, 7:651-665.
24. Cloutier M, Bolger FB, Lowry JP, Wellstead P. An integrative dynamical model of brain energy metabolism using in-vivo neurochemical measurements. Journal of Computational Neuroscience, 2009, 27(3):391-414.